Brutastrong-CV Dry Syrup

Brutastrong-CV Dry Syrup is a pharmaceutical product from Mankind Health Care. The vendor-provided composition is Cefpodoxime 50 mg combined with Clavulanic Acid 31.25 mg, presented as a dry syrup. The product is classified under Anti Biotics and originates from India. For information on clinical use, dosing, and safety, consult the product label or a healthcare professional.

Brutastrong-CV Dry Syrup is a medicine marketed by Mankind Health Care. The dry syrup composition as supplied by the vendor is Cefpodoxime 50 mg and Clavulanic Acid 31.25 mg. It is listed under the Antibiotics category and is supplied in a Bottal packaging type. The vendor facts do not include prescribing details, approved indications, dosing, contraindications, or safety information. Always refer to the printed product label, the patient information leaflet, your prescribing doctor, or the dispensing pharmacist for complete and authoritative guidance before use.

The vendor information does not describe clinical benefits or indications for Brutastrong-CV Dry Syrup. For clear information about the intended therapeutic uses and expected benefits, consult the printed patient leaflet, your prescribing doctor, or the dispensing pharmacist. They can explain why this specific formulation and combination were chosen and what outcomes to expect under supervision.

Cefpodoxime 50 mg + Clavulanic Acid 31.25 mg

Specific preparation and administration instructions are not provided in the vendor facts. Do not prepare or use the dry syrup without consulting the product label, your prescribing doctor, or the dispensing pharmacist. They will provide the exact reconstitution steps, the correct dose, and any age- or weight-based instructions. If in doubt, ask the pharmacist to demonstrate preparation and to supply an appropriate dosing device.

Do not use Brutastrong-CV Dry Syrup without a valid prescription and clear instructions from a healthcare professional. The vendor facts do not list contraindications, precautions, or patient selection criteria. Inform your prescriber about all current medications, known allergies, and medical conditions before using this medicine. Always check the product label and patient leaflet for safety information, and contact your pharmacist or doctor with any questions.

Vendor information does not provide specific warnings or contraindications. Prior to use, check the product label and patient leaflet and inform your prescriber about any allergies, existing medical conditions, or concurrent medications. Seek immediate medical attention if you experience unexpected reactions. Do not share prescription medicines or use another person’s medication.

The vendor information does not list storage conditions or shelf life for Brutastrong-CV Dry Syrup. For accurate storage instructions — including whether to refrigerate, acceptable temperature ranges, light protection, and how long the product remains usable after reconstitution — consult the medicine’s printed label, the patient leaflet, or ask the dispensing pharmacist. Always follow the expiry date and discard any unused medicine after that date or after the period stated for use following reconstitution. Keep medicines out of reach and sight of children.

Returns, cancellations and prescription checks are handled according to Angel Pharmaceutical policies and applicable healthcare rules. Product availability is confirmed during checkout.